Understanding how continuous glucose monitoring can predict diabetes development
Continuous glucose monitoring: determinants and prediction of diabetes mellitus development in the Framingham Heart Study
['FUNDING_R01'] · BOSTON UNIVERSITY MEDICAL CAMPUS · NIH-11046676
This study is looking at how continuous glucose monitoring can help spot blood sugar patterns in adults who might be at risk for diabetes, even if they don't have the usual warning signs, to better understand what affects their glucose levels over time.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOSTON UNIVERSITY MEDICAL CAMPUS (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11046676 on ClinicalTrials.gov |
What this research studies
This research investigates the use of continuous glucose monitoring (CGM) to identify glycemic patterns in adults, particularly those who may be at risk for diabetes mellitus (DM) but do not show traditional risk factors. By analyzing data from 2,700 participants in the Framingham Heart Study, the project aims to uncover how various factors such as body mass index, blood metabolites, and dietary habits influence glucose levels over time. The goal is to improve the prediction of diabetes risk by moving beyond single measurements to a more comprehensive understanding of glucose variability and its implications for health.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are part of the Framingham Heart Study and may have undiagnosed diabetes or prediabetes.
Not a fit: Patients who are under 21 years old or those who already have a confirmed diagnosis of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and intervention for individuals at risk of developing diabetes, potentially preventing the onset of the disease.
How similar studies have performed: Previous research using continuous glucose monitoring has shown promise in identifying glycemic patterns and predicting diabetes risk, suggesting that this approach could be effective.
Where this research is happening
BOSTON, UNITED STATES
- BOSTON UNIVERSITY MEDICAL CAMPUS — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SPARTANO, NICOLE L — BOSTON UNIVERSITY MEDICAL CAMPUS
- Study coordinator: SPARTANO, NICOLE L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: adult onset diabetes, Adult-Onset Diabetes Mellitus